Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | +0.33% | -11.05% | -17.22% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 15.01M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.87
x | P/E ratio 2025 * |
-1.38
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.33% |
1 day | -1.29% | ||
1 week | -11.05% | ||
Current month | -25.18% | ||
1 month | -30.22% | ||
3 months | -1.92% | ||
6 months | -11.05% | ||
Current year | -17.22% |
Managers | Title | Age | Since |
---|---|---|---|
Hyung-Heon Kim
CEO | Chief Executive Officer | 47 | 21-07-08 |
Director of Finance/CFO | 66 | 23-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Strickland
BRD | Director/Board Member | 77 | 22-01-26 |
Andrew Koven
CHM | Chairman | 66 | 21-07-08 |
Mark Glickman
BRD | Director/Board Member | 58 | 23-05-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.06 | -1.29% | 1 823 |
24-04-24 | 3.1 | +2.65% | 39,360 |
24-04-23 | 3.02 | -3.21% | 42,194 |
24-04-22 | 3.12 | -7.42% | 23,389 |
24-04-19 | 3.37 | -2.03% | 20,562 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.22% | 15.01M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+1.05% | 22.02B | |
-17.84% | 20.9B | |
-9.10% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- NRBO Stock